FDA Investigator Angela K Shen
Angela K Shen has conducted inspections on 4 sites in 3 countries as of 23 Jun 2005. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
23 Jun 2005
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United Kingdom of Great Britain and Northern Ireland,
Spain,
Germany
FDA Investigators that have inspected at least one site in common with Angela K Shen:
Anissa M Cheung,
Burnell M Henry,
Cassandra Overking,
Christian D Lynch (CDL),
Christine A Harman, PhD,
Cynthia Jim, CSO,
David M Beltran,
David S Cho, PhD,
Dr. Gang Wang, PhD,
Gene D Arcy,
Grace I Cortesini,
Helen B Ricalde,
J David Doleski,
Jacqueline Mdiaz Albertini,
James R Evans,
Joan A Loreng,
John D Finkbohner, PhD,
John M Mcinnis,
John M Mclnnis,
Julie D Bringger,
Laurie P Norwood,
Lewis K Antwi,
Marion Michaelis,
Mark A Elengold,
Michael Merchlinsky,
Mihaly S Ligmond,
Natalya M Ananyeva,
Nicholas Obiri, PhD,
Omotunde O Osunsanmi,
Paula A Trost,
Prabhu P Raju,
Qiao Y Bobo,
Rebecca K Olin,
Reginald D Neal,
Robert Jennings,
Robin Levis, PhD,
Rose Ashley,
Sergey S Akimov,
Shafiq S Ahadi,
Sidney B Priesmeyer,
Simone E Pitts,
Steven A Rubin,
Susan F Laska, MS,
Susan M Jackson,
Thai D Truong,
Unnee Ranjan,
Xiuju Lu,
Yiping Jia,
Zhiping Ye, PhD
Angela K Shen's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| January, 2002 | EIR | Instituto Grifols, S.A. - EIR, 2002-01-11 |
| May, 2001 | FDA 483 | Evans Vaccines Ltd. - Form 483, 2001-05-11 |
| January, 2002 | FDA 483 Response | Instituto Grifols, S.A. - Form 483R, 2002-02-11 |
| May, 2001 | FDA 483 Response | Seqirus Vaccines Limited - Form 483R, 2001-05-31 |
| June, 2005 | FDA 483 | SmithKline Beecham Pharma GmbH & Co. KG (dba GlaxoSmithKline Biologicals) - Form 483, 2005-06-29 |
| May, 2001 | EIR | Seqirus Vaccines Limited - EIR, 2001-05-11 |
| January, 2002 | FDA 483 | Instituto Grifols, S.A. - Form 483, 2002-01-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more